| Sarah Frederike Otter, DO | |
|
10200 N 92nd St Ste 200, Scottsdale, AZ 85258-4543 | |
| (480) 882-7410 | |
| (480) 451-9098 |
| Full Name | Sarah Frederike Otter |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 10200 N 92nd St Ste 200, Scottsdale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386149623 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 008979 (Arizona) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Honorhealth Scottsdale Shea Medical Center | Scottsdale, AZ | Hospital |
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Honorhealth Medical Group, Llc | 1557274057 | 224 |
News Archive
An enriched extract of the 'Indian Frankincense' herb Boswellia serrata has been proven to reduce the symptoms of osteoarthritis. Research published today in BioMed Central's open access journal Arthritis Research & Therapy has shown that patients taking the herbal remedy showed significant improvement in as little as seven days.
If you're having trouble getting a date, French researchers suggest that picking the right soundtrack could improve the odds. Women were more prepared to give their number to an 'average' young man after listening to romantic background music, according to research that appears today in the journal Psychology of Music, published by SAGE.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.
› Verified 3 days ago
| Entity Name | Honorhealth Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043851793 PECOS PAC ID: 1557274057 Enrollment ID: O20031119000717 |
News Archive
An enriched extract of the 'Indian Frankincense' herb Boswellia serrata has been proven to reduce the symptoms of osteoarthritis. Research published today in BioMed Central's open access journal Arthritis Research & Therapy has shown that patients taking the herbal remedy showed significant improvement in as little as seven days.
If you're having trouble getting a date, French researchers suggest that picking the right soundtrack could improve the odds. Women were more prepared to give their number to an 'average' young man after listening to romantic background music, according to research that appears today in the journal Psychology of Music, published by SAGE.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Frederike Otter, DO 10200 N 92nd St, 200, Scottsdale, AZ 85258 Ph: (480) 882-7410 | Sarah Frederike Otter, DO 10200 N 92nd St Ste 200, Scottsdale, AZ 85258-4543 Ph: (480) 882-7410 |
News Archive
An enriched extract of the 'Indian Frankincense' herb Boswellia serrata has been proven to reduce the symptoms of osteoarthritis. Research published today in BioMed Central's open access journal Arthritis Research & Therapy has shown that patients taking the herbal remedy showed significant improvement in as little as seven days.
If you're having trouble getting a date, French researchers suggest that picking the right soundtrack could improve the odds. Women were more prepared to give their number to an 'average' young man after listening to romantic background music, according to research that appears today in the journal Psychology of Music, published by SAGE.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.
› Verified 3 days ago
Dr. Sam Saman Fereidouni, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7699 E Pinnacle Peak Rd, Suite 115, Scottsdale, AZ 85255 Phone: 480-300-4663 Fax: 480-300-4888 | |
Dr. Daniel Andrew Wool, ND Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 20801 N Scottsdale Rd Suite 205, Scottsdale, AZ 85255 Phone: 480-389-3265 | |
Helene Wechsler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10900 N Scottsdale Rd, Suite 104, Scottsdale, AZ 85254 Phone: 480-990-1564 Fax: 480-990-3298 | |
Natasha Ryan, NMD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8412 E Shea Blvd, Suite 101, Scottsdale, AZ 85260 Phone: 480-874-1515 Fax: 480-991-8395 | |
Evan Scot Trost Ix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8328 E. Hartford Dr., Scottsdale, AZ 85255 Phone: 480-214-9720 Fax: 480-214-9722 | |
Katayoun Baniriah, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 4845 E Thunderbird Rd, Scottsdale, AZ 85254 Phone: 480-699-7004 Fax: 480-699-6129 | |
Dr. Ronald Lewis Peters, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13951 N Scottsdale Rd, Suite 100, Scottsdale, AZ 85254 Phone: 480-607-7999 Fax: 480-607-7998 |